卡莫司汀晶片植入物Carmustine治疗胶质母细胞瘤疗效显著
It is an alkylating drug indicated for: newly diagnosed high-grade malignant glioma as an adjunct to surgery and radiation and recurrent glioblastoma multiforme as an adjunct to surgery.
Carmustine chip implant is the world's only new drug for the treatment of malignant glioma. It is a white to off-white, dime-sized film containing the biodegradable polymer polyphenylene glycol 20 and 7.7 mg of carmustine (BCNU), a commonly used intravenously administered chemotherapy drug for the treatment of malignant gliomas.
Carmustine Chip Implant Carmustine is a type of carmustine contained in a chip. The wafer has a slowly dissolving coating and releases carmustine directly to the area where the tumor was removed. For brain tumors, this form may be better than other forms of carmustine, with fewer side effects.
Preclinical tests have proven that Carmustine chip implants can locally release high concentrations of carmustine (BCNU), which has obvious advantages over traditional methods. Compared with intraperitoneal administration, intracranial placement of Carmustine chip implants can increase local drug concentration by 4-1200 times. Based on its safety and good therapeutic effect on tumors, the United States and many countries around the world have successively approved the phase III clinical study of Carmustine chip implant. Combined with the test results, it can be seen that Carmustine chip implant has a significant effect in treating glioblastoma. This drug improves the patient's quality of life and disease progression, and can have a positive effect on the patient's condition.
The above is an introduction to Carmustine chip implant. If patients want to know more about the drug information of Carmustine chip implant (such as purchase channels, drug prices, usage methods, etc.), they can consult the medical companion travel service at any time.
Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.
Recommended hot articles:
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)